BioCentury
ARTICLE | Company News

Otsuka submits Japanese application for delamanid

March 28, 2013 12:13 AM UTC

Otsuka Pharmaceutical Co. Ltd. (Tokyo, Japan) submitted a regulatory application in Japan for delamanid to treat multi-drug resistant tuberculosis (MDR-TB) in combination with optimized background the...